Navigation Links
Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
Date:7/17/2008

SWARTZ CREEK, Mich., July 17 /PRNewswire/ -- Diplomat Specialty Pharmacy, the nation's largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximately 7500 patients. Without any offer of incentive, 568 surveys were returned to Diplomat, representing a very impressive 38% response rate.

Survey Says ...

-- 99% of patients are "satisfied" with Diplomat services, including a substantial 89% who are "very satisfied."

-- 98% of patients feel Diplomat meets their expectations "Most of the time," including a significant 86% who replied "All of the time."

-- 99% of patients say, "yes" they would recommend Diplomat to their family, friends and co-workers looking for a pharmacy.

"35 years ago Diplomat Specialty Pharmacy was built on personalized care, one patient at a time," said Phil Hagerman, President and CEO of Diplomat. "It is rewarding to know that we are successful because we still put our patients first. I congratulate all Diplomat employees whose high-touch patient care approach has led to industry leading patient satisfaction levels."

Diplomat contracted with Jarman-Johnson Communications and Gartner & Associates LLC to assist with survey analysis. The sampling error associated with a completed sample of 568 ranges from 0.8% to 4.1% at the 95% confidence level.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also s
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
2. CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
3. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
4. Patients Who Bring Health Information from the Internet Get More Time with Doctor
5. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
6. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
7. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
8. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
9. Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
10. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
11. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Budding Biomedical Scientists , ... School participated in the Scientific Enrichment and ... School of Medicine . , The ... professional experience in the sciences and brings them ... and students for both academic and career mentoring. ...
(Date:8/26/2014)... 2014 The 20 ambassadors representing the ... community issued the following statement on Facebook today regarding ... driving new funding specifically for ALS research: , “Who ... some ice would raise all this awareness and funding ... and on behalf of the entire ALS community, would ...
(Date:8/26/2014)...  ViveBio, LLC a leading provider of products ... announced today that it has signed a distribution ... Knoxville, Tennessee to distribute ... United States . ViveST is the first ... biological specimen transport systems.  The technology enables easy, ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
Breaking Biology Technology:Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3
... Microplasmin Shows Clear Promise in Back of the ... and Traction Release,Without Need for Vitrectomy, ThromboGenics ... vascular and eye diseases, will today present results ... American Society of Retina Specialists,(ASRS) 25th Annual Meeting ...
... review has concluded and verified the integrated performance of ... James Webb Space Telescope. , The Optical Telescope Element ... The telescope consists of a 6.5-meter (21.3 foot) primary ... structures, deployable tower and control electronics. , "The successful ...
... Nearly 5% of children and adolescents in U.S. may have high blood ... ... epidemic(2,3), - Diovan has a proven safety profile ... Diovan(R) (valsartan), an,angiotensin receptor blocker or ARB, has been approved following ...
Cached Biology Technology:ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting 2ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting 3ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting 4James Webb Space Telescope marks successful completion 2FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children 2FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children 3FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children 4FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children 5
(Date:8/27/2014)... abandoned each year in U.S. waters and become what ... fish, crabs, and other species such as turtles. These ... watermen who depend on the resources--losses that are largely ... The report, published in the Marine Pollution Bulletin ... the derelict fish trap problem, and so-called "ghost fishing," ...
(Date:8/27/2014)... have shown that excessive iron is closely ... Previous studies from Chunyan Guo and co-workers ... shown that baicalin prevented iron accumulation after ... 1 expression, and increased ferroportin 1 expression ... disease rats. However, the relationship between iron ...
(Date:8/27/2014)... research has shown that piglets can be weaned later ... The outcome of the study at the University,s Roseworthy ... , is an important finding for pig producers. It ... of production. , "Sows don,t usually start their oestrous ... their piglets have been weaned," says Ms Alice Weaver, ...
Breaking Biology News(10 mins):NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2Piglet weaning age no bar to litter frequency 2
... to change an incandescent light bulb to a more environmentally ... that figure is approximately 1,000. Thats the number of staff ... Star Change a Light, Change the World Campaign. In ... pledged to replace at least one incandescent bulb or fixture ...
... seawater to produce an electric field, a behavior that ... the bycatch of sharks in longline gear. Shark ... of many shark species, and because sharks compete with ... increasing operating costs. A recent study by NOAA ...
... For the first time researchers are beginning to understand ... Massachusetts General Hospital (MGH) investigators, in collaboration with ... days of vigorous athletic training produces significant changes in ... change varies with the type of exercise performed. ...
Cached Biology News:Can certain metals repel sharks from fishing gear? 2Can certain metals repel sharks from fishing gear? 3Mass. General study shows how exercise changes structure and function of heart 2
...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
Mouse Wnt-9b Affinity Purified Polyclonal Ab Keywords: Wnt 9b Protein Family: Cancer Stem Cell Markers, Wnt Ligands...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
Biology Products: